Clinical Trials on Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 Variant in Brazil

Total 1 results

University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Pharmacogenetic and Pharmacokinetics of Naproxen and Associated Naproxen-esomeprazole

Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant

Brazil

3

Subscribe